Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments
Open Access
- 21 February 2026
- journal article
- Published by Taylor & Francis in Future Science OA
- Vol. 12 (1) , 2629346
Abstract
Flavin-containing monooxygenase 3 (FMO3) is a key metabolic enzyme involved in endogenous metabolism; however, its role in colorectal cancer (CRC) remains poorly understood. This study aimed to investigate the expression pattern, biological function, and potential clinical relevance of FMO3 in CRC. Publicly available transcriptomic datasets were analyzed to assess FMO3 expression and its association with clinical characteristics. Immunohistochemistry and in vitro functional assays were performed to evaluate the effects of FMO3 on CRC cell proliferation, cell-cycle progression, migration, and invasion. Bioinformatics analyses were used to explore potential signaling pathways and immune-related associations. FMO3 was significantly upregulated in CRC tissues and cell lines and was associated with unfavorable clinicopathological features and poor prognosis. Silencing of FMO3 inhibited CRC cell proliferation by inducing G0/G1 cell-cycle arrest and suppressed migration and invasion by reversing epithelial-mesenchymal transition-related phenotypes. Mechanistically, FMO3 depletion attenuated PI3K/AKT signaling activity. In addition, FMO3 expression was correlated with immune cell infiltration patterns and immune checkpoint-related molecules. FMO3 promotes malignant progression of colorectal cancer and may serve as a potential biomarker and therapeutic target. Further in vivo and mechanistic studies are warranted to validate these findings.Keywords
Funding Information
- Provincial Science and Technology Program of Gansu Province (23JRRA1527)
- Entrepreneurship Project of Science and Technology bereau of Chengguan District of Lanzhou city (2023-2-6)
- anzhou City Science and Technology Project (2023-ZD-199)
- Planning Project of the Health Industry in Gansu Province (GSWSKY2022-73)
This publication has 30 references indexed in Scilit:
- Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancerOncology Letters, 2018
- Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial DysfunctionCellular Physiology and Biochemistry, 2017
- Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and DiseaseDrug Metabolism and Disposition, 2016
- Global patterns and trends in colorectal cancer incidence and mortalityGut, 2016
- A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fatBMC Genomics, 2015
- Plasma Choline Metabolites and Colorectal Cancer Risk in the Women's Health Initiative Observational StudyCancer Research, 2014
- Regulation of flavin-containing mono-oxygenase ( Fmo3 ) gene expression by steroids in mice and humansHormone Molecular Biology and Clinical Investigation, 2014
- Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary RegulationCell Metabolism, 2013
- Inter-individual Variation in Flavin-containing Monooxygenase 3 in Livers from Japanese: Correlation with Hepatic Transcription FactorsDrug Metabolism and Pharmacokinetics, 2009
- Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in KoreansCancer Science, 2006